Comparative 50% protective dose assays (PD50) of Marke's disease virus strain CVI988
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Journal of Biological Standardization
- Vol. 9 (1) , 15-22
- https://doi.org/10.1016/s0092-1157(81)80061-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Differential effect of maternal antibodies on efficacy of cellular and cell‐free Marek's disease vaccinesAvian Pathology, 1979
- Wirksamkeitsprüfungen mit PHV‐, MHV‐ und JMV‐Vakzinen gegen die Marek'sche KrankheitAvian Pathology, 1978
- Influence of Age at Exposure on the Pathogenesis of Marek's Disease 2JNCI Journal of the National Cancer Institute, 1973
- Control of Marek's Disease in the Netherlands. I. Isolation of an Avirulent Marek's Disease Virus (Strain CVI 988) and Its Use in Laboratory Vaccination TrialsPublished by JSTOR ,1972
- Protection against Marek's Disease by Vaccination with a Herpesvirus of TurkeysPublished by JSTOR ,1970
- Some Virological and Serological Observations On Marek’s Disease: A Preliminary ReportBritish Veterinary Journal, 1969
- Immunization against Marek's Disease using a Live Attenuated VirusNature, 1969
- Independent-Action and Birth-Death Models in Experimental MicrobiologyMicrobiology and Molecular Biology Reviews, 1965
- PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSESThe Journal of Experimental Medicine, 1954